Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity

被引:1004
作者
Movahedi, Kiavash [1 ,2 ]
Guilliams, Martin [1 ,2 ]
Van den Bossche, Jan [1 ,2 ]
Van den Bergh, Rafael [1 ,2 ]
Gysemans, Conny [3 ]
Beschin, Alain [1 ,2 ]
De Baetselier, Patrick [1 ,2 ]
Van Ginderachter, Jo A. [1 ,2 ]
机构
[1] Vrije Univ Brussel, Cellular & Mol Immunol Lab, B-1050 Brussels, Belgium
[2] VIB, Dept Mol & Cellular Interact, Cellular & Mol Immunol Lab, Brussels, Belgium
[3] Katholieke Univ Leuven, Dept Expt Med, Lab Expt Med & Endocrinol, Louvain, Belgium
关键词
D O I
10.1182/blood-2007-07-099226
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The induction of CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSCs) is an important immune-evading mechanism used by tumors. However, the exact nature and function of MDSCs remain elusive, especially because they constitute a heterogeneous population that has not yet been clearly defined. Here, we identified 2 distinct MDSC subfractions with clear morphologic, molecular, and functional differences. These fractions consisted of either mononuclear cells (MO-MDSCs), resembling inflammatory monocytes, or low-density polymorphonuclear cells (PMN-MDSCs), akin to immature neutrophils. Interestingly, both MO-MDSCs and PMN-MDSCs suppressed anti gen-specific T-cell responses, albeit using distinct effector molecules and signaling pathways. Blocking IFN-gamma or disrupting STAT1 partially impaired suppression by MO-MDSCs, for which nitric oxide (NO) was one of the mediators. In contrast, while IFN-gamma was strictly required for the suppressor function of PMN-MDSCs, this did not rely on STAT1 signaling or NO production. Finally, MO-MDSCs were shown to be potential precursors of highly antiproliferative NO-producing mature macrophages. However, distinct tumors differentially regulated this inherent MO-MDSC differentiation program, indicating that this phenomenon was tumor driven. Overall, our data refine tumor-induced MDSC functions by uncovering mechanistically distinct MDSC subpopulations, potentially relevant for MDSC-targeted therapies.
引用
收藏
页码:4233 / 4244
页数:12
相关论文
共 49 条
[1]   Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon γ-dependent cyclooxygenase 2 expression [J].
Blanco, JCG ;
Contursi, C ;
Salkowski, CA ;
DeWitt, DL ;
Ozato, K ;
Vogel, SN .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (12) :2131-2144
[2]   Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+ T cells [J].
Bronte, V ;
Apolloni, E ;
Cabrelle, A ;
Ronca, R ;
Serafini, P ;
Zamboni, P ;
Restifo, NP ;
Zanovello, P .
BLOOD, 2000, 96 (12) :3838-3846
[3]   Regulation of immune responses by L- arginine metabolism [J].
Bronte, V ;
Zanovello, P .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (08) :641-654
[4]  
Bronte V, 1999, J IMMUNOL, V162, P5728
[5]   IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice [J].
Bronte, V ;
Serafini, P ;
De Santo, C ;
Marigo, I ;
Tosello, V ;
Mazzoni, A ;
Segal, DM ;
Staib, C ;
Lowel, M ;
Sutter, G ;
Colombo, MP ;
Zanovello, P .
JOURNAL OF IMMUNOLOGY, 2003, 170 (01) :270-278
[6]   Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression [J].
Bunt, SK ;
Sinha, P ;
Clements, VK ;
Leips, J ;
Ostrand-Rosenberg, S .
JOURNAL OF IMMUNOLOGY, 2006, 176 (01) :284-290
[7]   Tie2 identifies a hematopoietic monocytes required for tumor lineage of proangiogenic vessel formation and a mesenchymal population of pericyte progenitors [J].
De Palma, M ;
Venneri, MA ;
Galli, R ;
Sergi, LS ;
Politi, LS ;
Sampaolesi, M ;
Naldini, L .
CANCER CELL, 2005, 8 (03) :211-226
[8]  
Eklund EA, 1999, J IMMUNOL, V163, P6095
[9]   Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo [J].
Gabrilovich, D ;
Ishida, T ;
Oyama, T ;
Ran, S ;
Kravtsov, V ;
Nadaf, S ;
Carbone, DP .
BLOOD, 1998, 92 (11) :4150-4166
[10]   Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells [J].
Gabrilovich, DI ;
Velders, MP ;
Sotomayor, EM ;
Kast, WM .
JOURNAL OF IMMUNOLOGY, 2001, 166 (09) :5398-5406